相关实验视频

Updated: Sep 12, 2025

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

氧化调增强细胞毒性,减少前列腺癌纳米治疗中的炎症

Joana Claudio Pieretti¹, Giovana Marchini Armentano¹, Marcela Sorelli Carneiro-Ramos¹

¹Center for Natural and Human Sciences (CCNH), Federal University of ABC (UFABC), Santo André, SP, Brazil.

Nitric oxide : biology and chemistry

|August 6, 2025

概括

改变前列腺癌细胞中的氧化 (NO) 水平,提高了对纳米粒子治疗的敏感性. 增加和减少NO水平都改善了治疗结果,这表明NO平衡是纳米药物疗效的关键.

科学领域:

生物医学工程生物医学工程
在瘤学瘤学.
纳米医学是一种纳米医学.

背景情况:

细胞内氧化物 (NO) 调制是改进基于纳米粒子的癌症疗法的潜在策略.
前列腺癌细胞 (PC3) 是研究NO在治疗反应中的作用的焦点.

研究的目的:

为了研究调节细胞内NO水平对PC3细胞中含有西斯的氧化纳米颗粒 (ZnO/CisPt NPs) 疗效的影响.
确定通过增加或减少改变NO平衡是否会影响瘤细胞对纳米药物的敏感性.

主要方法:

使用S-nitrosoglutathione (GSNO) 作为NO的捐赠者和L-nitro arginine甲基 (l-NAME) 作为氧化合成酶 (NOS) 抑制剂来调节细胞内NO水平.
在不同的NO条件下,向PC3细胞注入加载 cisplatin 的氧化纳米颗粒 (ZnO/CisPt NPs).
评估了NOS表达和炎症性细胞因子调节的变化.

主要成果:

使用NO捐赠剂和抑制剂的NO调制增强了ZnO/CisPtNP对PC3细胞的治疗性能.
调制导致NOS表达减少,并改变了炎症性细胞因子配置.
增加和耗尽的细胞内S-NO水平都使瘤细胞对纳米粒子治疗敏感.

结论:

改变细胞内NO平衡,无论方向如何,对于使前列腺癌细胞对基于纳米粒子的疗法敏感至关重要.
NO 信号在增强纳米药物的有效性和最大限度地减少瘤炎症方面发挥着重要作用.
这种方法为前列腺癌治疗提供了一个潜在的更安全,更有针对性的策略,具有更广泛的瘤应用.

关键词:

炎症炎症是一种炎症.氧化调制的氧化调制氧化合成酶是一种氧化合成酶.前列腺癌是什么意思前列腺癌是什么意思氧化纳米颗粒的氧化物.

更多相关视频

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

相关概念视频

Nitric Oxide Signaling Pathway

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Antihypertensive Drugs: Vasodilators

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...